AngioDynamics (ANGO) Total Debt to Capital

The price trend for the total debt-to-equity ratio of AngioDynamics, Inc. (ANGO) is 0.07. AngioDynamics, Inc. (ANGO) develops innovative devices for minimally invasive treatment of vessels and tumors in collaboration with clinics. The company's environmental policy is based on standard polymer recycling and workshop energy efficiency. However, rising global tensions and export restrictions on electronics may limit the brand's expansion in foreign markets.

AngioDynamics, Inc. (ANGO) patents for minimally invasive equipment create a significant barrier to entry for competitors. By analyzing the historical total debt-to-equity ratio, an investor assesses the business's degree of financial leverage. This ratio compares total liabilities against net shareholder equity. A downward trend indicates deleveraging, although it may signal a move away from aggressive growth. This metric determines the stability of the company's capital structure.